| In vivo analysis of intramuscular gene transfer in human subjects studied by on-line ultrasound imaging. | |
| | |
MedLine Citation:
|
PMID: 11506696 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The current study was designed to test the hypothesis that intramuscular (i.m.) injection of naked DNA leads to distribution of the injectate remote from the site of needle placement, a finding that might be expected to facilitate i.m. gene transfer. Transcutaneous ultrasound imaging was employed to monitor online the extent to which a solution of phVEGF165 was distributed among the skeletal musculature during 288 i.m. injections in 18 consecutive patients. In 237 (82.3%) of 288 muscle sites, the injection was performed into the distal calf muscle. In 51 (17.7%) of 288 muscle sites, injection was performed into the first and/or second interosseous muscles of the dorsal foot. Unperturbed muscle was recognized by a characteristic echogenic, stippled texture that was bounded by more intensely echogenic fascia. When i.m. gene transfer was performed into the calf muscles, the injectate was distributed along a longitudinal dimension of 3.59 +/- 0.79 cm (1.39-5.87 cm); the corresponding area of injectate measured by on-line planimetry was 1.83 +/- 0.51 cm2 (0.62-3.41 cm2). When i.m. gene transfer was performed into the interosseous muscles of the foot, the longitudinal extent of injectate distribution was 2.49 +/- 0.66 cm (1.61-3.91 cm), with a corresponding injectate area of 1.71 +/- 0.54 cm2 (0.51-2.86 cm2). These findings establish that a solution of plasmid DNA administered by direct i.m. injection into the skeletal muscles of the limb is distributed well beyond the site of needle entry. Thus, the use of multiple injections performed at different sites is likely to result in broad distribution of DNA injectate, a physical factor that may act to facilitate naked DNA and/or other gene transfer strategies. |
| | |
Authors:
|
G Rauh; A Pieczek; W Irwin; R Schainfeld; J M Isner |
Related Documents
:
|
1461376 - Hemimasticatory spasm: clinical and electrophysiologic observations. 8957446 - Myotoxic activity of the toxic phospholipase, notexin, from the venom of the australian... 16785106 - Neurophysiological effects of botulinum toxin type a. 2560846 - An extract of lionfish (pterois volitans) spine tissue contains acetylcholine and a tox... 18509576 - Patients with acute spinal cord injury benefit from normocapnic hyperpnoea training. 16179406 - Altered reflex cardiovascular control during exercise in heart failure: animal studies. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Human gene therapy Volume: 12 ISSN: 1043-0342 ISO Abbreviation: Hum. Gene Ther. Publication Date: 2001 Aug |
Date Detail:
|
Created Date: 2001-08-16 Completed Date: 2001-11-01 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 9008950 Medline TA: Hum Gene Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 1543-9 Citation Subset: IM |
Affiliation:
|
Shaughnessy Center for Clinical Genetics, Department of Medicine, Vascular Medicine, St. Elizabeth's Medical Center, Tuft's University School of Medicine, Boston, MA 02135, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
DNA
/
administration & dosage*,
metabolism* Endothelial Growth Factors / genetics Extremities / blood supply* Gene Therapy / methods Gene Transfer Techniques* Humans Ischemia / therapy* Leg / ultrasonography Lymphokines / genetics Muscle, Skeletal / metabolism, ultrasonography Muscles / metabolism*, ultrasonography* Plasmids / administration & dosage, metabolism Time Factors Ultrasonics* Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors |
| Grant Support | |
ID/Acronym/Agency:
|
HL53354/HL/NHLBI NIH HHS; HL57516/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Endothelial Growth Factors; 0/Lymphokines; 0/Vascular Endothelial Growth Factor A; 0/Vascular Endothelial Growth Factors; 9007-49-2/DNA |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo.
Next Document: Sustainable systemic delivery via a single injection of lentivirus into human skin tissue.